STSA Annual CFI
$43.37 M
+$94.15 M+185.41%
31 December 2022
Summary:
As of February 5, 2025, STSA annual cash flow from investing activities is $43.37 million, with the most recent change of +$94.15 million (+185.41%) on December 31, 2022. During the last 3 years, it has risen by +$139.25 million (+145.24%).STSA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA Quarterly CFI
$14.48 M
+$26.53 M+220.18%
31 March 2023
Summary:
As of February 5, 2025, STSA quarterly cash flow from investing activities is $14.48 million, with the most recent change of +$26.53 million (+220.18%) on March 31, 2023. Over the past year, it has dropped by -$5.86 million (-28.80%).STSA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA TTM CFI
$37.51 M
-$5.86 M-13.51%
31 March 2023
Summary:
As of February 5, 2025, STSA TTM cash flow from investing activities is $37.51 million, with the most recent change of -$5.86 million (-13.51%) on March 31, 2023. Over the past year, it has increased by +$67.60 million (+224.66%).STSA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +185.4% | -28.8% | +224.7% |
| 3 y3 years | +145.2% | +6.1% | +145.6% |
| 5 y5 years | +10000.0% | - | +139.1% |
STSA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -25.2% | -29.4% | -35.3% |
Satsuma Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $14.48 M(-220.2%) | $37.51 M(-13.5%) |
| Dec 2022 | $43.37 M(-185.4%) | -$12.05 M(-158.7%) | $43.37 M(+0.8%) |
| Sept 2022 | - | $20.51 M(+40.8%) | $43.04 M(+102.7%) |
| June 2022 | - | $14.57 M(-28.4%) | $21.24 M(-170.6%) |
| Mar 2022 | - | $20.34 M(-264.3%) | -$30.09 M(-40.7%) |
| Dec 2021 | -$50.78 M(-187.5%) | -$12.38 M(+859.0%) | -$50.78 M(+48.2%) |
| Sept 2021 | - | -$1.29 M(-96.5%) | -$34.26 M(+175.2%) |
| June 2021 | - | -$36.76 M(>+9900.0%) | -$12.45 M(-128.3%) |
| Mar 2021 | - | -$344.00 K(-108.3%) | $44.00 M(-24.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $58.00 M(-160.5%) | $4.14 M(-79.8%) | $58.00 M(<-9900.0%) |
| Sept 2020 | - | $20.52 M(+4.2%) | -$233.00 K(-99.6%) |
| June 2020 | - | $19.69 M(+44.2%) | -$54.65 M(-33.5%) |
| Mar 2020 | - | $13.65 M(-125.2%) | -$82.20 M(-14.3%) |
| Dec 2019 | -$95.88 M(>+9900.0%) | -$54.09 M(+59.6%) | -$95.88 M(+129.5%) |
| Sept 2019 | - | -$33.90 M(+331.1%) | -$41.78 M(+429.9%) |
| June 2019 | - | -$7.86 M(>+9900.0%) | -$7.88 M(>+9900.0%) |
| Mar 2019 | - | -$22.00 K | -$22.00 K |
| Dec 2018 | -$402.00 K(+593.1%) | - | - |
| Dec 2017 | -$58.00 K | - | - |
FAQ
- What is Satsuma Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals annual CFI year-on-year change?
- What is Satsuma Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals quarterly CFI year-on-year change?
- What is Satsuma Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals TTM CFI year-on-year change?
What is Satsuma Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of STSA is $43.37 M
What is the all time high annual CFI for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high annual cash flow from investing activities is $58.00 M
What is Satsuma Pharmaceuticals annual CFI year-on-year change?
Over the past year, STSA annual cash flow from investing activities has changed by +$94.15 M (+185.41%)
What is Satsuma Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of STSA is $14.48 M
What is the all time high quarterly CFI for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high quarterly cash flow from investing activities is $20.52 M
What is Satsuma Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, STSA quarterly cash flow from investing activities has changed by -$5.86 M (-28.80%)
What is Satsuma Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of STSA is $37.51 M
What is the all time high TTM CFI for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high TTM cash flow from investing activities is $58.00 M
What is Satsuma Pharmaceuticals TTM CFI year-on-year change?
Over the past year, STSA TTM cash flow from investing activities has changed by +$67.60 M (+224.66%)